The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil–Associated Coronary VasospasmAmna Zafar, Tomas G. Neilan, Matthew Lei et al.|JACC CardioOncology|2021Cited by 74
The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasmAmna Zafar, Tomas G. Neilan, Zsófia D. Drobni et al.|PLoS ONE|2022Cited by 27